Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
01 Sep 2019
Historique:
received: 22 03 2019
revised: 23 04 2019
accepted: 12 05 2019
pubmed: 28 5 2019
medline: 26 7 2019
entrez: 27 5 2019
Statut: ppublish

Résumé

The class of tetrahydro-1H-3-benzazepines was systematically modified in 1-, 3- and 7-position. In particular, a F-atom was introduced in β- or γ-position of the 4-phenylbutyl side chain in 3-position. Ligands with the F-atom in γ-position possess higher GluN2B affinity than analogs bearing the F-atom in β-position. This effect was attributed to the reduced basicity of β-fluoro amines. 3-Benzazepines with a benzylic OH moiety show moderate GluN2B affinity, but considerable selectivity over the σ

Identifiants

pubmed: 31129453
pii: S0223-5234(19)30444-1
doi: 10.1016/j.ejmech.2019.05.034
pii:
doi:

Substances chimiques

Analgesics 0
Benzazepines 0
Excitatory Amino Acid Antagonists 0
Ligands 0
NR2B NMDA receptor 0
Piperidines 0
Receptors, N-Methyl-D-Aspartate 0
Receptors, sigma 0
ifenprodil R8OE3P6O5S

Types de publication

Journal Article

Langues

eng

Pagination

47-62

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Simone Thum (S)

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.

Dirk Schepmann (D)

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.

Eva Ayet (E)

Esteve Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain.

Marta Pujol (M)

Esteve Pharmaceuticals S.A, Baldiri Reixach 4-8, 08028 Barcelona, Spain.

Francisco R Nieto (FR)

Department of Pharmacology and Institute of Neuroscience, School of Medicine and Biomedical Research Center, University of Granada, Avenida de la Investigación 11, 18016 Granada, Spain.

Simon M Ametamey (SM)

Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.

Bernhard Wünsch (B)

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), Westfälische Wilhelms-Universität Münster, Germany. Electronic address: wuensch@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH